Trilogy Writing and Consulting Logo

Glossary Terms

Office of New Drugs

The Office, within the US Food and Drug Administration, responsible for providing regulatory oversight for investigational studies during drug development. The Office makes decisions regarding marketing approval for new (innovator or non-generic) drugs, including license decision changes related to previously approved and already marketed products.

Use our tool to look up the definition of terms in our glossary.